Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (2798)	8/15/2003 5:42:52 PM
From: JoeinIowa	Respond to of 23958

Sergio, My latest small obscure stock is ALRG. Nice earnings at .06 for 6 months and paid down bank debt to zero this quarter. Nice growth rate. I would suggest we replace CRV with ALRG. Thoughts anyone? Joe Press Release Source: Allergy Research Group, Inc. Allergy Research Group, Inc. Reports Profits For Second Quarter 2003 Thursday August 14, 3:19 pm ET HAYWARD, Calif.--(BUSINESS WIRE)--Aug. 14, 2003--Allergy Research Group, Inc. (OTCBB:ALRG - News) announced financial results for the second quarter ending June 30, 2003. ALRG recorded total revenue of $3,447,130 for the quarter, up 7% from 2002. The increase of $213,005 is primarily due to increased sales to distributors and increased demand at retail for current and new products. Total revenue for the first quarter 2003 was $3,448,762. "We are very encouraged by our ability to sustain our current level of sales," said Chief Executive Officer and Chairman, Dr. Stephen A. Levine, Ph.D. Cost of sales decreased $43,653 to $1,990,480 for the quarter ended June 30, 2003, compared to $2,034,133 for the quarter ended June 30, 2002, as a result of higher margins at retail and reduced freight costs. Gross profit margins increased approximately 5.2%, approximating 42.8% for 2003 resulting from the higher margins associated with retail sales. During the quarter ended June 30, 2003, the Company recorded net income of $427,488, as compared to net income of $221,693 for the same period in 2002. The increase is a reflection of the increase in sales and higher profit margins. Interest expense decreased $9,936 for the quarter ended June 30, 2003, as compared to June 30, 2002 as result of the Company paying down its line of credit from $570,064 at December 31, 2001 to zero at June 30, 2003. On August 12, 2003, Manfred (Fred) Salomon was appointed President of the Company. Mr. Salomon was hired in 2002 to fill the role of Director of Operations. He brings 40 years of executive management experience. Complete copies of the company's financial statements, including notes to the financials, can be found on its website at www.nutricology.com.